产品编号 :
Cas No. :
CAS No. |
260371-16-2 |
|---|---|
中文名称 |
4-(4-氟苯甲酰基)-3-(羟甲基)苯甲腈 |
英文名称 |
4-(4-Fluorobenzoyl)-3-(hydroxymethyl)benzonitrile |
别名 |
4-(4-fluorobenzoyl)-3-(hydroxyMethyl)benzonitrile;Citalopram Impurity 4;Citalopram Related Compound VI;Benzonitrile, 4-(4-fluorobenzoyl)-3-(hydroxymethyl)-;Citalopram Impurity 31;Escitalopram oxalate impurity 04 |
标准英文名 |
4-(4-fluorobenzoyl)-3-(hydroxymethyl)benzonitrile |
分子式 |
C15H10FNO2 |
分子量 |
255.25 |
精确分子量 |
255.07 |
SMILES |
N#CC1=CC=C(C(C2=CC=C(F)C=C2)=O)C(CO)=C1 |
标准SMILES |
N#CC1C=C(CO)C(=CC=1)C(=O)C1C=CC(F)=CC=1 |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes.Not for drug or household use. |
信号词 |
Warning |
InChIKey |
GDOCLIOVHKLEOU-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry, 2-8°C,resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral , acute toxicity, dermal and acute toxicity, inhalation (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation(Category 2A),Specific target organ toxicity, single exposure;Respiratory system(Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|